Health Care International finds a buyer

Article

An investment group based in Abu Dhabi has agreed in principleto take over Health Care International, the $290 million high-techScottish hospital that filed for receivership late last year (SCAN12/14/94). Abu Dhabi Investment Co. has agreed to buy the

An investment group based in Abu Dhabi has agreed in principleto take over Health Care International, the $290 million high-techScottish hospital that filed for receivership late last year (SCAN12/14/94). Abu Dhabi Investment Co. has agreed to buy the hospitaland operate it as a going concern, although details of the dealhave not yet been worked out.

HCI was conceived as a state-of-the-art health-care facilitybased near Glasgow that would cater to wealthy patients from Europe,the Middle East and North Africa. The project was unable to generateenough patient revenue and was forced to file for receivershiponly five months after opening.

Medical imaging vendors who sold equipment to HCI are followingthe negotiations over its future closely. A spokesperson for theLondon office of Arthur Andersen, the receiver for HCI, said allthe facility's medical equipment is still on site and that suppliersare cooperating fully.

Other parties are interested in HCI, but negotiations withthem have been postponed to allow the Abu Dhabi group to completethe purchase. The spokesperson said a deal should be completedby the end of January.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.